-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on Vera Therapeutics, Lowers Price Target to $91

Benzinga·05/15/2026 17:39:49
Listen to the news
Evercore ISI Group analyst Gavin Clark-Gartner maintains Vera Therapeutics (NASDAQ:VERA) with a Outperform and lowers the price target from $95 to $91.